LCID
Lucid Group, Inc.
LCID lost money over the past year, so it has no meaningful PE right now. Analysts expect losses to shrink, though they disagree widely on how much.
XWEL
XWELL, Inc.
There isn't enough reported data to score XWEL yet.
LCID Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Weak | |
| Weak | |
| Unavailable |
LCID's revenue is currently healthy, but its profitability and cash flow are weak. There isn't enough data to rate its balance sheet.
XWEL Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Weak | |
| Under pressure | |
| Strong |
XWEL's balance sheet is currently strong, and its revenue is stable, but its profitability and cash flow are under pressure.
LCID PE Valuation
LCID has no meaningful PE right now: it lost money over the past year.
XWEL PE Valuation
XWEL has no meaningful PE right now: it lost money over the past year.
LCID Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong growth | |
| -- | |
| Limited | |
| Low |
Analysts expect LCID's losses to shrink, with revenue growing. However, they disagree widely on these estimates.
XWEL Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong growth | |
| -- | |
| Limited | |
| High |
Analysts expect XWEL's losses to shrink, with revenue growing.
LCID Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$13.08 | -$2.57 |
| Q2 2026 | -$13.65 | -$2.35 |
| Q1 2026 | -$13.15 | -$1.25 |
| Q4 2025 | -$12.09 | +$0.41 |
| Q3 2025 | -$10.51 | +$2.49 |
| Q2 2025 | -$11.30 | +$0.40 |
| Q1 2025 | -$11.90 | +$0.40 |
| Q4 2024 | -$12.50 | +$1.10 |
LCID has the edge over XWEL on earnings, with more consistent year-over-year improvement.
XWEL Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | -$5.29 | -$1.15 |
| Q1 2026 | -$5.59 | -$1.53 |
| Q4 2025 | -$5.08 | -$1.42 |
| Q3 2025 | -$3.41 | -$0.26 |
| Q2 2025 | -$4.14 | +$0.40 |
| Q1 2025 | -$4.06 | +$1.40 |
| Q4 2024 | -$3.66 | +$2.60 |
| Q3 2024 | -$3.15 | +$5.03 |
XWEL is still losing money, but far less than before: $5.29 per share over the past year, against $668.33 at its worst in late 2019.
LCID Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $350.3M | +4.1% |
| Q2 2026 | $405.3M | +56% |
| Q1 2026 | $282.5M | +20% |
| Q4 2025 | $522.7M | +123% |
| Q3 2025 | $336.6M | +68% |
| Q2 2025 | $259.4M | +29% |
| Q1 2025 | $235M | +36% |
| Q4 2024 | $234.5M | +49% |
LCID has the edge over XWEL on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -245% | +35 points |
| Q2 2026 | -267% | +43 points |
| Q1 2026 | -350% | -56 points |
| Q4 2025 | -204% | +109 points |
| Q3 2025 | -280% | +105 points |
| Q2 2025 | -310% | +83 points |
| Q1 2025 | -294% | +128 points |
| Q4 2024 | -313% | +156 points |
LCID's operating margin was −245% last quarter, up 35 points from the same quarter a year ago, near the top of its range since 2020.
XWEL Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $7.1M | -7.1% |
| Q1 2026 | $6.6M | -5.5% |
| Q4 2025 | $7.2M | -4.2% |
| Q3 2025 | $7.3M | -13% |
| Q2 2025 | $7.7M | -17% |
| Q1 2025 | $7M | -20% |
| Q4 2024 | $7.5M | +0.9% |
| Q3 2024 | $8.4M | +13% |
XWEL's revenue has slid since its 2021 peak: $7M last quarter, down 7.1% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | -29% | +5.6 points |
| Q1 2026 | -82% | -37 points |
| Q4 2025 | -127% | -24 points |
| Q3 2025 | -10% | +46 points |
| Q2 2025 | -35% | -15 points |
| Q1 2025 | -45% | -18 points |
| Q4 2024 | -103% | -34 points |
| Q3 2024 | -57% | +84 points |
XWEL has the edge over LCID on profitability, with a higher operating margin.
LCID Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$1B | -$84.2M |
| Q2 2026 | -$1.5B | -$463.2M |
| Q1 2026 | -$1.4B | -$849M |
| Q4 2025 | -$1.2B | -$417.1M |
| Q3 2025 | -$955.5M | -$333M |
| Q2 2025 | -$1B | -$271.6M |
| Q1 2025 | -$589.9M | +$125.1M |
| Q4 2024 | -$824.8M | -$77.6M |
LCID has burned cash in almost every quarter: −$5.2B over the past year, against −$3.4B the year before.
XWEL Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | -$4.7M | -$1.4M |
| Q1 2026 | -$5M | -$390K |
| Q4 2025 | -$748K | +$3.4M |
| Q3 2025 | -$3.1M | +$774K |
| Q2 2025 | -$3.3M | -$2.5M |
| Q1 2025 | -$4.6M | -$629K |
| Q4 2024 | -$4.2M | -$726K |
| Q3 2024 | -$3.8M | +$833K |
XWEL has the edge over LCID on cash flow, with more consistent year-over-year improvement.
LCID Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +3.3% | +12.5M shares |
| 1 year | +26% | +82.4M shares |
| 3 years | +73% | +166M shares |
LCID has the edge over XWEL on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q4 2020 | $2.2M |
| Q1 2020 | — |
XWEL Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +15% | +1.1M shares |
| 1 year | +61% | +3.2M shares |
| 3 years | +104% | +4.3M shares |
| 5 years | +68% | +3.4M shares |
XWEL has 8M diluted shares, up 61% from a year ago.
| Quarter | Spent |
|---|---|
| Q2 2026 | — |
| Q1 2026 | $9M |
| Q4 2022 | — |
| Q3 2022 | $11.7M |
| Q2 2022 | $1M |
| Q1 2022 | $11.1M |
| Q4 2021 | $7.4M |
LCID Net Leverage
LCID's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
XWEL Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q1 2022 | -13.0x | Net Cash |
| Q4 2021 | -14.0x | Net Cash |
XWEL has more cash than debt.
LCID Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 32.9 | Neutral |
| Stochastic | 7.1 | Oversold |
LCID's weekly RSI is 33 (neutral) and its Stochastic is 7 (oversold).
XWEL Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 29.3 | Oversold |
| Stochastic | 10.6 | Oversold |
XWEL's weekly RSI is 29 (oversold) and its Stochastic is 11 (oversold).
LCID PE vs Consumer Cyclical Sector
LCID has no meaningful PE right now: it lost money over the past year.
XWEL PE vs Consumer Cyclical Sector
XWEL has no meaningful PE right now: it lost money over the past year.
LCID Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $3.53 | 7.9% below |
| 20 week MA | $4.88 | 33% below |
| 50 week MA | $7.33 | 56% below |
| 100 week MA | $15.4 | 79% below |
| 200 week MA | $31.9 | 90% below |
LCID is in a downtrend: it's below all five of its weekly moving averages, and 90% below its 200-week average.
XWEL Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $0.73 | 23% below |
| 20 week MA | $0.89 | 37% below |
| 50 week MA | $0.94 | 40% below |
| 100 week MA | $0.99 | 43% below |
| 200 week MA | $2.14 | 74% below |
XWEL is in a downtrend: it's below all five of its weekly moving averages, and 74% below its 200-week average.
LCID Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $98.9 | $100.4 | +1.5% |
| 2021 | $100.4 | $376.4 | +275% |
| 2022 | $376.4 | $67.0 | -82% |
| 2023 | $67.0 | $42.1 | -37% |
| 2024 | $42.1 | $32.0 | -24% |
| 2025 | $32.0 | $11.4 | -64% |
| 2026 YTD | $11.4 | $3.25 | -72% |
LCID has finished four years in a row lower, and it's down 72% so far in 2026.
XWEL Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $36.6 | $27.0 | -26% |
| 2021 | $27.0 | $40.0 | +48% |
| 2022 | $40.0 | $7.60 | -81% |
| 2023 | $7.60 | $1.74 | -77% |
| 2024 | $1.74 | $1.63 | -6.3% |
| 2025 | $1.63 | $0.62 | -62% |
| 2026 YTD | $0.62 | $0.56 | -9.7% |
XWEL has the edge over LCID on returns for 2026, with the stronger performance.